Malignancies, prothrombotic mutations, and the risk of venous thrombosis

Article Abstract:

The study aimed to identify individuals with cancer with an increased thrombotic risk, evaluating different tumor sites, the presence of distant metabases, and carrier status of prothrombotic mutations. It concluded that patients with cancer have a highly increased risk of venous thrombosis especially in the first few months after diagnosis and in the presence of distant metastases.

Risk factors, Thrombophlebitis, Cancer patients

---

Antiangiogenic therapy a two-trick pony?

Article Abstract:

Antiangiogenic therapy reports revealed that its ability to bring oxygen and nutrients to tumors were not enough to combat established tumors in humans. Thus, an antiangiogenic agent could kill many to most cancer cells, but the remaining cancer cells would begin to make new angiogenic molecules and new blood vessels would come up again.

Science & research, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Angina Treatment Preps, Research, Drug therapy, Dosage and administration, Cancer cells, Angiogenin, Antiangina agents

---

Beyond the teachable moment

Article Abstract:

The lack of fundamental understanding by the public about the nature of science and scientific evidence represents a growing obstacle to the biomedical research. The public engagement is suggested as an alternative health care approach, which would allow biomedical researchers to serve the society better.

Alternative medicine

Similar abstracts:

• Abstracts: Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility and early outcomes: Feasibility and early outcomes
• Abstracts: Delaying generic competition - Corporate payoffs and the future of Plavix. Approving the vagus-nerve stimulator for depression
• Abstracts: Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients
• Abstracts: Making patient nutrition a top priority. Assaults on staff show 5% drop
• Abstracts: Telomerase mutations in families with idiopathic pulmonary fibrosis. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.